Survival outcomes and prognostic factors in salvage surgery for advanced non-small cell lung cancer: a 10-year single-center experience
Yazarlar (8)
Prof. Dr. Özgür ÖZTÜRK Türkiye
Kenan Can Ceylan
Onur Akcay
Seyda Ors Kaya
Ahmet Ucvet
Soner Gursoy
Aysen Evkan Ozturk
Ozgur Samancilar Kastamonu Üniversitesi
| Makale Türü |
Özgün Makale
(Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale)
|
||
| Dergi Adı | Current Thoracic Surgery | ||
| Makale Dili | – | Basım Tarihi | 07-2025 |
| Cilt / Sayı / Sayfa | 10 / 3 / – | DOI | – |
| Makale Linki | http://cts.tgcd.org.tr/abstract.php?id=270 | ||
| UAK Araştırma Alanları |
Süper İletkenler
|
||
| Özet |
| Materials and Methods: Patients operated on for non-small cell lung cancer between January 2006 and December 2016 were examined. Among these patients, 51 patients who underwent R0 resection after definitive chemotherapy and/or radiotherapy were evaluated.Results: The mean age was 57.58±6.78 (46-78) years in 46 male and 5 female patients. Thirty-two (62.74%) patients had chemotherapy at the definitive dose, 16 (31.37%) received chemoradiotherapy, 3 (5.88%) underwent high-dose radiotherapy. The mean duration between treatment and surgery was 14±10.89 (6-74) weeks. Thirty-two patients were clinically evaluated as Stage 3A, while 19 as Stage 3B and referred to definitive therapy. Thirty (63%) patients underwent lobectomy and 19 (37%) pneumonectomy. Forty-two patients (82.35%) had no complications, and there were complications in 9 (17.65%) patients. Postoperative mortality occurred in four (7.8%) patients. Five-year survival was calculated as 36.6%, and the median survival was 34 months. Median progression-free survival was 26.23 months.Conclusion:" Salvage surgery" has been considered a feasible method in experienced centers with acceptable morbidity and mortality in selected patients with advanced lung cancer. |
| Anahtar Kelimeler |
